Hormone Replacement Therapy

Hormone replacement therapy can also be named as the menopausal hormone therapy or the postmenopausal hormone therapy. The main aim of this therapy is to treat menopause. The main hormones used in the HRT are oestrogen and progesterone. Sometimes androgens such as testosterone are also used. Unchecked prescription of oestrogen therapy can cause endometrial thickening which can result in the progression of the cancer. However this hormone replacement therapy should be strictly contraindicated in the conditions such as severe liver diseases, coronary artery diseases, pregnancy, vaginal bleeding and aggressive breast, uterine or ovarian cancers.

 

  • Post-menopausal hormone therapy
  • Oestrogen therapy
  • Progesterone
  • Coronary artery disease
  • Vaginal bleeding
  • Endometrial thickening

Related Conference of Hormone Replacement Therapy

June 15-16, 2026

5th World Congress on Women Health and Gynecology

Paris, France
August 27-28, 2026

12th Asia Pacific Gynecology and Obstetrics Congress

Paris, France

Hormone Replacement Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in